CFTR and cystic fibrosis: Five of the ten CF subjects were taking CFTR modulators at the time of phlebotomy, three subjects were taking combination ivacaftor/lumacaftor, one subject was taking combination ivacaftor/tezacaftor, and one subject was taking combination ivacaftor/tezacaftor/elexacaftor.